Research Projects
Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFβ antagonists in synergistic combined cancer
Researcher | Principal Investigator
Combination Strategies for Translational Immunotherapy Research Group
Research Division
Cancer Division
Research program
Immunology and Immunotherapy
Research group
Combined translational immunotherapy strategies
Project information
Research project called Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFβ antagonists in synergistic combined cancer belonging to the research group Combined Strategies of Translational Immunotherapy research group of the Cima University of Navarra.
- Convocation: Proyectos I+D+i - Modalidad Generación del Conocimiento
- Reference: PID2020-112892RB- 100
- Start date: September 1, 2021
- End date: August 31, 2024
- Funder: Ministerio de Ciencia, Innovación y Universidades
- Nature of project: National
- Award year 2021
Need more information?
If you are interested in learning more about our research, please contact us.